Cannaflos Genetics S.L.

Cannaflos Genetics S.L. is dedicated to advancing the development of novel cannabis cultivars registered within the EU, with a focus on improving the quality of life for patients through cutting-edge cannabinoid-based medications. As an integral part of the Cannaflos Group, Cannaflos Genetics S.L. leverages the synergy of expertise from various business units to provide comprehensive solutions that meet the evolving needs of both clients and the global market.

Cannaflos Genetics S.L. actively collaborates with universities and research institutions on numerous R&D projects, emphasizing genetic preservation, development, and breeding. Through strong partnerships and state-of-the-art laboratory infrastructure, Cannaflos Genetics S.L. is well-positioned to enhance the Cannaflos portfolio and expand its capabilities in customized cannabis genetics development. The company is committed to innovation and excellence in the pharmaceutical sector.

Cannaflos Genetics S.L. is excited about the future and invites you to explore the many possibilities that our commitment to research and development can offer. We believe that our dedication to quality and innovation will make a significant impact on the pharmaceutical industry. We invite the manager of Cannaflos Genetics S.L. to create a customized and exclusive company showcase and product listing on our platform to further highlight their expertise and offerings.